ImageneBio, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
ImageneBio, Inc. (IMA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.42 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-10
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.42M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $4.21M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.92M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.83M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $2.42M 10-K · filed 2026-03-10 |
| 2024-12-31 | $4.21M 10-K · filed 2025-03-06 |
| 2023-12-31 | $3.92M 10-K · filed 2024-03-12 |
| 2022-12-31 | $1.83M 10-K · filed 2023-03-14 |
| 2021-12-31 | $1.77M 10-K · filed 2022-03-17 |
| 2021-09-30 | $1.77M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.77M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.77M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |